Form 4: Alamar Biosciences Insider Sells Shares
Insider Transaction (Form 4)
Qiming Corporate GP VI, Ltd. and 6 others reported changes in beneficial ownership of Alamar Biosciences, Inc. common stock on November 11, 2026.
Summary
- Open-market sale: disposed of 1,694 Common Stock at $29.34 ($49,702) on November 11, 2026; holds 157,273 after (Indirect).
- Open-market sale: disposed of 56 Common Stock at $30.63 ($1,715) on November 11, 2026; holds 157,217 after (Indirect).
- Open-market sale: disposed of 62,944 Common Stock at $29.34 ($1,846,777) on November 11, 2026; holds 5,844,859 after (Indirect).
- Open-market sale: disposed of 2,084 Common Stock at $30.63 ($63,833) on November 11, 2026; holds 5,842,775 after (Indirect).
- Open-market sale: disposed of 14,687 Common Stock at $29.34 ($430,917) on November 11, 2026; holds 1,363,787 after (Indirect).
- Open-market sale: disposed of 486 Common Stock at $30.63 ($14,886) on November 11, 2026; holds 1,363,301 after (Indirect).
- Open-market sale: disposed of 17,584 Common Stock at $29.34 ($515,915) on November 11, 2026; holds 1,632,770 after (Indirect).
- Open-market sale: disposed of 582 Common Stock at $30.63 ($17,827) on November 11, 2026; holds 1,632,188 after (Indirect).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,941,571 of stock on the open market.
Insider Transactions
Qiming Corporate GP VI, Ltd. — 10% owner
Qiming Managing Directors Fund VI, L.P. — 10% owner
Qiming Venture Partners VI, L.P. — 10% owner
Qiming GP VIII, LLC — 10% owner
Qiming Venture Partners VIII Investments, LLC — 10% owner
Qiming GP VIII-HC, LLC — 10% owner
Qiming Venture Partners VIII-HC, L.P. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-11 | Open-market sale | Common Stock | 1,694 | $29 | $49.7K | 157,273 |
| 2026-11-11 | Open-market sale | Common Stock | 56 | $31 | $1.7K | 157,217 |
| 2026-11-11 | Open-market sale | Common Stock | 62,944 | $29 | $1.8M | 5,844,859 |
| 2026-11-11 | Open-market sale | Common Stock | 2,084 | $31 | $63.8K | 5,842,775 |
| 2026-11-11 | Open-market sale | Common Stock | 14,687 | $29 | $430.9K | 1,363,787 |
| 2026-11-11 | Open-market sale | Common Stock | 486 | $31 | $14.9K | 1,363,301 |
| 2026-11-11 | Open-market sale | Common Stock | 17,584 | $29 | $515.9K | 1,632,770 |
| 2026-11-11 | Open-market sale | Common Stock | 582 | $31 | $17.8K | 1,632,188 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-11 | Open-market sale (1,694 shares) |
| 2026-11-11 | Open-market sale (56 shares) |
| 2026-11-11 | Open-market sale (62,944 shares) |
| 2026-11-11 | Open-market sale (2,084 shares) |
| 2026-11-11 | Open-market sale (14,687 shares) |
| 2026-11-11 | Open-market sale (486 shares) |
| 2026-11-11 | Open-market sale (17,584 shares) |
| 2026-11-11 | Open-market sale (582 shares) |
Keywords
insider transaction, Form 4, ALMR, Alamar Biosciences, Inc., bearish, Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming GP VIII-HC, LLC, Qiming Venture Partners VIII-HC, L.P.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.